A vaccine made by connecting antigens from different flu strains together elicited a more broadly protective immune response than a conventional flu vaccine.
Researchers uncovered the structural details of how low-density lipoprotein (LDL), or “bad,” cholesterol, interacts with its receptor molecule to enter cells.